(VIANEWS) – The Market ended the session with MEDINCELL (MEDCL.PA) jumping 14.41% to €10.16 on Tuesday, following the last session’s downward trend. CAC 40 slid 1.45% to €7,383.20, after two consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.
MEDINCELL’s last close was €8.88, 14.29% below its 52-week high of €10.36.
About MEDINCELL
MedinCell S.A. develops various therapeutic solutions in France. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension completed Phase III trial for use in the treatment of schizophrenia; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-TJK, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials, such as mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for use in organ transplant; mdc-WWM for contraception; mdc-STM for use in malaria; mdc-KPT for use in acute pain for pets; and mdc-IRM for use in neuroscience. The company was incorporated in 2003 and is based in Jacou, France.
Earnings Per Share
As for profitability, MEDINCELL has a trailing twelve months EPS of €-1.05.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEDINCELL’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
MEDINCELL’s stock is valued at €10.16 at 22:35 EST, below its 52-week high of €10.36 and way above its 52-week low of €4.73.
Moving Average
MEDINCELL’s worth is way above its 50-day moving average of €8.92 and way higher than its 200-day moving average of €6.80.
Volume
Today’s last reported volume for MEDINCELL is 541200 which is 1135.64% above its average volume of 43799.
More news about MEDINCELL (MEDCL.PA).
